Wu Yushan, Cheng Rui, Lin Hao, Li Lili, Jia Yongbin, Philips Anna, Zuo Tao, Zhang Hu
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China.
Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.
BMC Med. 2025 Mar 26;23(1):183. doi: 10.1186/s12916-025-04016-y.
Inflammatory bowel disease (IBD) refers to chronic, recurrent inflammatory intestinal disorders, primarily including Crohn's disease (CD) and Ulcerative colitis (UC). Numerous studies have elucidated the importance of the gut microbiome in IBD. Recently, numerous studies have focused on the gut virome, an intriguing and enigmatic aspect of the gut microbiome. Alterations in the composition of phages, eukaryotic viruses, and human endogenous retroviruses that occur in IBD suggest potential involvement of the gut virome in IBD. Nevertheless, the mechanisms by which it maintains intestinal homeostasis and interacts with diseases are only beginning to be understood. Here, we thoroughly reviewed the composition of the gut virome in both healthy individuals and IBD patients, emphasizing the key viruses implicated in the onset and progression of IBD. Furthermore, the complex connections between the gut virome and the intestinal barrier, immunity, and gut microbiome were dissected to advance the interpretation of IBD pathogenesis. The updated discussion of the evidence regarding the gut virome will advance our knowledge in gut virome and chronic gastrointestinal diseases. Targeting the gut virome is a promising avenue for IBD treatment in future.
炎症性肠病(IBD)是指慢性、复发性炎症性肠道疾病,主要包括克罗恩病(CD)和溃疡性结肠炎(UC)。众多研究已阐明肠道微生物群在IBD中的重要性。最近,众多研究聚焦于肠道病毒组,这是肠道微生物群中一个引人关注且神秘的方面。IBD中发生的噬菌体、真核病毒和人类内源性逆转录病毒组成的改变表明肠道病毒组可能参与了IBD。然而,其维持肠道稳态以及与疾病相互作用的机制才刚刚开始被了解。在此,我们全面回顾了健康个体和IBD患者肠道病毒组的组成,强调了与IBD发病和进展相关的关键病毒。此外,剖析了肠道病毒组与肠道屏障、免疫和肠道微生物群之间的复杂联系,以深化对IBD发病机制的理解。关于肠道病毒组证据的最新讨论将增进我们对肠道病毒组和慢性胃肠疾病的认识。靶向肠道病毒组是未来IBD治疗的一个有前景的途径。